Latest: FDA Approves New Biosimilar for Oncology Treatment

CentralReach Acquires SpectrumAi and AI.Measures to Expand AI-Powered Autism Care

0 Mins
What You Should Know: – CentralReach, a software provider for autism and intellectual and developmental disabilities (IDD) care, has announced the acquisitions of SpectrumAi and AI.Measures. These strategic moves significantly expand CentralReach’s platform to enable and accelerate outcomes-based care (OBC) for the autism and IDD field. – The two companies bring cutting-edge capabilities in clinical ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago